Literature DB >> 24452739

Prostate cancer nomograms: a review of their use in cancer detection and treatment.

R J Caras1, Joseph R Sterbis.   

Abstract

As prostate cancer treatment discussions have grown more complex, increasing numbers of nomograms to guide decision-making have been found in the literature. Such nomograms can influence every step in the prostate cancer therapeutic process, from determining the need for biopsy to the need for adjuvant therapy. With a properly counseled patient who is aware of the limitations of nomograms, such tools assist in the shared decision-making that characterizes modern informed consent.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24452739     DOI: 10.1007/s11934-013-0391-0

Source DB:  PubMed          Journal:  Curr Urol Rep        ISSN: 1527-2737            Impact factor:   3.092


  52 in total

1.  Predicting the risk of lymph node invasion during radical prostatectomy using the European Association of Urology guideline nomogram: a validation study.

Authors:  J Schmitges; P I Karakiewicz; M Sun; F Abdollah; L Budäus; H Isbarn; M Bianchi; Q-D Trinh; T Schlomm; F K Chun; M Graefen; T Steuber
Journal:  Eur J Surg Oncol       Date:  2012-04-22       Impact factor: 4.424

2.  Validation of a nomogram for prediction of side specific extracapsular extension at radical prostatectomy.

Authors:  Thomas Steuber; Markus Graefen; Alexander Haese; Andreas Erbersdobler; Felix K-H Chun; Thorsten Schlom; Paul Perrotte; Hartwig Huland; Pierre I Karakiewicz
Journal:  J Urol       Date:  2006-03       Impact factor: 7.450

3.  Decision curve analysis: a discussion.

Authors:  Ewout W Steyerberg; Andrew J Vickers
Journal:  Med Decis Making       Date:  2008 Jan-Feb       Impact factor: 2.583

4.  A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer.

Authors:  M W Kattan; J A Eastham; A M Stapleton; T M Wheeler; P T Scardino
Journal:  J Natl Cancer Inst       Date:  1998-05-20       Impact factor: 13.506

5.  External validation of the updated nomogram predicting lymph node invasion in patients with prostate cancer undergoing extended pelvic lymph node dissection.

Authors:  Mauro Gacci; Riccardo Schiavina; Michele Lanciotti; Lorenzo Masieri; Sergio Serni; Valerio Vagnoni; Firas Abdollah; Marco Carini; Giuseppe Martorana; Francesco Montorsi
Journal:  Urol Int       Date:  2012-12-22       Impact factor: 2.089

6.  Development and internal validation of a Prostate Health Index based nomogram for predicting prostate cancer at extended biopsy.

Authors:  Giovanni Lughezzani; Massimo Lazzeri; Alessandro Larcher; Giuliana Lista; Vincenzo Scattoni; Andrea Cestari; Nicoló Maria Buffi; Vittorio Bini; Giorgio Guazzoni
Journal:  J Urol       Date:  2012-08-15       Impact factor: 7.450

7.  Nomogram use for the prediction of indolent prostate cancer: impact on screen-detected populations.

Authors:  Stijn Roemeling; Monique J Roobol; Michael W Kattan; Theo H van der Kwast; Ewout W Steyerberg; Fritz H Schröder
Journal:  Cancer       Date:  2007-11-15       Impact factor: 6.860

Review 8.  Comparison of nomograms with other methods for predicting outcomes in prostate cancer: a critical analysis of the literature.

Authors:  Shahrokh F Shariat; Pierre I Karakiewicz; Nazareno Suardi; Michael W Kattan
Journal:  Clin Cancer Res       Date:  2008-07-15       Impact factor: 12.531

9.  A nomogram for predicting upgrading in patients with low- and intermediate-grade prostate cancer in the era of extended prostate sampling.

Authors:  Ayman S Moussa; Michael W Kattan; Ryan Berglund; Changhong Yu; Khaled Fareed; J Stephen Jones
Journal:  BJU Int       Date:  2009-08-13       Impact factor: 5.588

10.  A nomogram for predicting low-volume/low-grade prostate cancer: a tool in selecting patients for active surveillance.

Authors:  Hiroyuki Nakanishi; Xuemei Wang; Atsushi Ochiai; Kiril Trpkov; Asli Yilmaz; J Bryan Donnelly; John W Davis; Patricia Troncoso; R Joseph Babaian
Journal:  Cancer       Date:  2007-12-01       Impact factor: 6.860

View more
  10 in total

1.  Can nomograms improve our ability to select candidates for active surveillance for prostate cancer?

Authors:  V Iremashvili; M Manoharan; D J Parekh; S Punnen
Journal:  Prostate Cancer Prostatic Dis       Date:  2016-07-19       Impact factor: 5.554

2.  Post-operative nomogram for predicting freedom from recurrence after surgery in localised breast cancer receiving adjuvant hormone therapy.

Authors:  Chafika Mazouni; Frédéric Fina; Sylvie Romain; Pascal Bonnier; L'houcine Ouafik; Pierre-Marie Martin
Journal:  J Cancer Res Clin Oncol       Date:  2014-11-30       Impact factor: 4.553

Review 3.  Risk stratification of prostate cancer: integrating multiparametric MRI, nomograms and biomarkers.

Authors:  Matthew J Watson; Arvin K George; Mahir Maruf; Thomas P Frye; Akhil Muthigi; Michael Kongnyuy; Subin G Valayil; Peter A Pinto
Journal:  Future Oncol       Date:  2016-07-12       Impact factor: 3.404

4.  Diagnostic performance of 68Ga-PSMA PET/CT in the detection of prostate cancer prior to initial biopsy: comparison with cancer-predicting nomograms.

Authors:  Jingliang Zhang; Shuai Shao; Peng Wu; Daliang Liu; Bo Yang; Donghui Han; Yu Li; Xiaoyu Lin; Wei Song; Milin Cao; Jing Zhang; Fei Kang; Weijun Qin; Jing Wang
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-01-11       Impact factor: 9.236

Review 5.  Random biopsy: when, how many and where to take the cores?

Authors:  Vincenzo Scattoni; Carmen Maccagnano; Umberto Capitanio; Andrea Gallina; Alberto Briganti; Francesco Montorsi
Journal:  World J Urol       Date:  2014-06-08       Impact factor: 4.226

6.  sE-cadherin serves as a diagnostic and predictive parameter in prostate cancer patients.

Authors:  Igor Tsaur; Kristina Thurn; Eva Juengel; Kilian M Gust; Hendrik Borgmann; Rene Mager; Georg Bartsch; Elsie Oppermann; Hanns Ackermann; Karen Nelson; Axel Haferkamp; Roman A Blaheta
Journal:  J Exp Clin Cancer Res       Date:  2015-05-14

7.  Does prostate acinar adenocarcinoma with Gleason Score 3+3=6 have the potential to metastasize?

Authors:  Rodolfo Montironi; Marina Scarpelli; Roberta Mazzucchelli; Antonio Lopez-Beltran; Matteo Santoni; Alberto Briganti; Francesco Montorsi; Liang Cheng
Journal:  Diagn Pathol       Date:  2014-10-18       Impact factor: 2.644

8.  Novel concepts for risk stratification in prostate cancer.

Authors:  Keval M Patel; Vincent J Gnanapragasam
Journal:  J Clin Urol       Date:  2016-12-01

Review 9.  Utility of Lymphadenectomy in Prostate Cancer: Where Do We Stand?

Authors:  Bartosz Małkiewicz; Paweł Kiełb; Jakub Karwacki; Róża Czerwińska; Paulina Długosz; Artur Lemiński; Łukasz Nowak; Wojciech Krajewski; Tomasz Szydełko
Journal:  J Clin Med       Date:  2022-04-22       Impact factor: 4.241

10.  Prediction models for prostate cancer to be used in the primary care setting: a systematic review.

Authors:  Mohammad Aladwani; Artitaya Lophatananon; William Ollier; Kenneth Muir
Journal:  BMJ Open       Date:  2020-07-19       Impact factor: 2.692

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.